Showing 1 - 12 results of 12 for search 'Priddy F', query time: 0.03s
Refine Results
-
1
P06-01. Developing a sponsor-initiated clinical guidance for AIDS vaccine research by Excler J-L, Becker J, Priddy F
Published 2009-10-01Article -
2
-
3
-
4
Utility of different adherence measures for PrEP: Patterns and incremental value by Abaasa, A, Hendrix, C, Gandhi, M, Anderson, P, Kamali, A, Kibengo, F, Sanders, E, Mutua, G, Bumpus, N, Priddy, F, Haberer, J
Published 2017Journal article -
5
High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populati... by Van der Elst, E, Mbogua, J, Operario, D, Mutua, G, Kuo, C, Mugo, P, Kanungi, J, Singh, S, Haberer, J, Priddy, F, Sanders, E
Published 2012Journal article -
6
A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study by Lindegger G, Quayle M, Singh S, Welsh S, Mark D, Wallace M, Roux S, Bekker L, Mwananyanda L, Kilembe W, Chomba E, Allen S, Priddy F, Fast P
Published 2012-09-01Article -
7
Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. by Mutua, G, Sanders, E, Mugo, P, Anzala, O, Haberer, J, Bangsberg, D, Barin, B, Rooney, J, Mark, D, Chetty, P, Fast, P, Priddy, F
Published 2012Journal article -
8
AIDS vaccines and preexposure prophylaxis: is synergy possible? by Excler, J, Rida, W, Priddy, F, Gilmour, J, McDermott, AB, Kamali, A, Anzala, O, Mutua, G, Sanders, E, Koff, W, Berkley, S, Fast, P
Published 2011Journal article -
9
Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures. by Baxi, S, Liu, A, Bacchetti, P, Mutua, G, Sanders, E, Kibengo, F, Haberer, J, Rooney, J, Hendrix, C, Anderson, P, Huang, Y, Priddy, F, Gandhi, M
Published 2015Journal article -
10
Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa by Ngongo BP, Priddy F, Park H, Bender B, Fast P, Anzala O, Mutua G, Ruzagira E, Kamali A, Karita E, Mugo P, Chomba E, Bekker L, Roux S, Nanvubya A, Mebrahtu T
Published 2012-09-01Article -
11
African Early Infection Cohort as a Platform for Vaccine Discovery: The IAVI Protocol C Experience. by Gilmour, J, Kamali, A, Karita, E, Kilembe, W, Sanders, E, Anzala, O, Allen, S, Edward, V, Priddy, F, Price, M, Macharia, G, Baalwa, J, Crotty, S, Denny, T, Landais, E, Borrow, P, Tang, J, Busch, M, Prince, J, Claiborne, D, Poignard, P, Fast, P, Hunter, E
Published 2014Journal article -
12
Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection by Price, M, Rida, W, Kilembe, W, Karita, E, Inambao, M, Ruzagira, E, Kamali, A, Sanders, E, Anzala, O, Hunter, E, Allen, S, Edward, V, Wall, K, Tang, J, Fast, P, Kaleebu, P, Lakhi, S, Mutua, G, Bekker, L, Abu-Baker, G, Tichacek, A, Chetty, P, Latka, M, Maenetje, P, Makkan, H, Kibengo, F, Priddy, F, Gilmour, J
Published 2019Journal article